
Could China’s New GLP-1 Drugs Beat Out Ozempic?
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes
Rachel Fieldhouse is a reporter for Nature News.
Could China’s New GLP-1 Drugs Beat Out Ozempic?
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes
Who Is on RFK, Jr.’s New Vaccine Panel—And What Will They Do?
Critics fear that U.S. Department of Health and Human Services chief RFK, Jr., known for his antivaccine views, has picked a crucial CDC committee that will be a “disaster for public health”
A Japanese Spacecraft Has Crash-Landed on the Moon—Again
Investigations by the Japanese company ispace identified issues with speed and an altitude sensor that likely doomed the lander
Black Death Plague That Killed Millions Became Less Fatal because of This Genetic Tweak
Reducing the copies of one gene in the bubonic plague bacterium, Yersinia pestis, made it less deadly but potentially more transmissible